DSG2 and plasma cell myeloma: As DSG2 has also been shown to be expressed by other stem/progenitor cell populations [12, 61], it is our contention that the expression of DSG2 in myeloma lacking the t(4;14) translocation reflects a partial de‐differentiation of plasma cells to a haematopoietic stem cell‐like phenotype.